HOME >> MEDICINE >> NEWS
Landmark clinical trial at 22 medical centers finds implanted heart pumps lengthen and improve lives of terminally ill heart failure patients

Implanted heart pumps can extend and improve the quality of life of terminally ill heart failure patients, a three-year landmark study of 129 patients at 22 major medical centers has found.

Supervised by investigators at Columbia University's International Center for Health Outcomes and Innovation Research, the multi-center and multi-sponsored REMATCH (Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure) trial found that the use of an implanted heart pump with wearable controls more than doubled the likelihood that terminally ill heart failure patients would be alive at the end of one year. These patients were either too sick or too old to be candidates for a heart transplant.

The researchers found that patients with the implanted device had a 52.1 percent chance of surviving a year compared with a 24.7 percent survival rate for patients who took drugs and were medically monitored. The likelihood of survival for two years in patients with the device was 22.9 percent vs. 8.1 percent in the other group.

The findings of the approximately $25 million trial are being published in the November 12 early web site edition of the New England Journal of Medicine. The results are being presented the same day at the 2001 American Heart Association scientific sessions in Anaheim, Calif.

"This trial transforms decades of hopeful research into the development of man-made machines to support the failing heart into a successful long-term treatment," says Dr. Eric Rose, chairman of surgery at Columbia Presbyterian Medical Center of NewYork-Presbyterian Hospital, the Morris and Rose Milstein/Johnson & Johnson Professor of Surgery at Columbia University College of Physicians & Surgeons, and principal investigator of the study.

Columbia University, the National Heart, Lung and Blood Institute (NHLBI), and Thoratec Corporation, the Pleasanton, Calif.-based manufacturer of the HeartMate VE device used in t
'"/>

Contact: Annie Bayne
as862@columbia.edu
Columbia University Medical Center
15-Nov-2001


Page: 1 2 3 4

Related medicine news :

1. Landmark survey reveals asthma in children remains significantly out of control in the United States
2. Landmark antidepressant analysis demonstrated significant efficacy of Effexor®/Effexor XR
3. Landmark study shows coenzyme Q10 slows progressive decline in Parkinsons disease
4. Landmark XENDOS study shows Xenical prevents or delays the development of type 2 diabetes
5. Landmark study demonstrates potential for nerve regeneration treatment of stroke
6. Landmark study results published in NEJM highlight breakthrough treatment for heart failure
7. Landmark study uncovers reasons behind recurring back injury
8. Landmark dialysis study findings could greatly simplify treatment of kidney disease with peritoneal dialysis
9. Landmark school-based social influences smoking-prevention program found not to work
10. U.S., British scientific societies honor penicillin as International Chemical Landmark
11. CODE-2*: Landmark study on the costs of type 2 diabetes in Europe

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... AURORA, Colo. (PRWEB) , ... August 31, 2020 ... ... premier provider of innovative higher-learning opportunities through high-quality, career-relevant, and affordable online education ... Emergency Responder Psychology . , Among the first of its kind in ...
(Date:8/31/2020)... ... 2020 , ... In an effort to give back to the community in ... each hotel room booked with a special new rate code to benefit children and ... effective immediately. Donations will be applied to any room type, any time, now ...
(Date:8/28/2020)... , ... August 28, 2020 , ... ... & CEO Craig Mandeville was named an Entrepreneur Of The Year® 2020 Florida ... honors entrepreneurial business leaders whose ambitions deliver innovation, growth and prosperity as they ...
(Date:8/28/2020)... ... August 28, 2020 , ... Integrated Viral Protection (IVP Air) ... school to deploy its breakthrough Mobile Biodefense Indoor Air Protection System that is the ... Academy plans to fully reopen equipped with the filtration system on September 8th. ...
(Date:8/27/2020)... ... August 27, 2020 , ... The team at Sikara MedSpa ... wellness retreat. The practice is centered on results and providing the ultimate patient ... Designed to be a sanctuary for total body renewal and aesthetic revitalization, Sikara ...
Breaking Medicine News(10 mins):
(Date:9/1/2020)... ... ... Breast and ovarian cancers are common diseases that affect many women. According ... women per year) and 10% of ovarian cancers (about 2,000 women per year) result ... in the Women’s Excellence Genetic Testing Program. , Dr. Jonathan Zaidan, MD, FACOG, President ...
(Date:8/31/2020)... ... August 31, 2020 , ... Cloudticity announced ... named Cloudticity a Gold winner in the 15th Annual 2020 Network PG’s IT ... o ns from Network Products Guide honoring achievements of world’s best in ...
(Date:8/27/2020)... , ... August 27, 2020 , ... Austin Oral Surgery ... is pleased to announce Dr. David Szalay, DDS, MD, has joined the practice. An ... in the new Pflugerville office, which is scheduled to open this fall. The new ...
Breaking Medicine Technology:
Cached News: